Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
66.6M
-
Number of holders
-
219
-
Total 13F shares, excl. options
-
68.6M
-
Shares change
-
+2.28M
-
Total reported value, excl. options
-
$1.42B
-
Value change
-
+$36.7M
-
Put/Call ratio
-
0.94
-
Number of buys
-
100
-
Number of sells
-
-130
-
Price
-
$20.77
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q3 2023
281 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q3 2023.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 219 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68.6M shares
.
Largest 10 shareholders include BlackRock Inc. (8.86M shares), VANGUARD GROUP INC (7M shares), Capital World Investors (6.55M shares), EMINENCE CAPITAL, LP (5.49M shares), FMR LLC (2.99M shares), JANUS HENDERSON GROUP PLC (2.67M shares), STATE STREET CORP (2.17M shares), Bellevue Group AG (2.14M shares), Capital International Investors (1.79M shares), and ArrowMark Colorado Holdings LLC (1.63M shares).
This table shows the top 219 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.